The fact that VEGF-B increases perfusion and improves insulin delivery in obese adipose tissue could be important for the therapy of T2DM in two principal ways: (i) increased availability of insulin to target organs improves insulin sensitivity and (ii) insulin-induced capillary recruitment and increased blood flow facilitates glucose uptake in target organs [29]. This evidence concerns the gene VEGFB and type 2 diabetes mellitus.